We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New Company and collaboration to develop Novel Therapeutics Including Vonoprazan for the Treatment of Acid-Related Disorders in North America and Europe